US 10202366
Methods of promoting wound healing using CRM1 inhibitors
granted A61KA61K31/41A61K31/4196
Quick answer
US patent 10202366 (Methods of promoting wound healing using CRM1 inhibitors) held by Karyopharm Therapeutics Inc. expires Mon Feb 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Karyopharm Therapeutics Inc.
- Grant date
- Tue Feb 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/41, A61K31/4196, A61P, A61P17/02